Both CVS and Walgreens are now selling CBD products. Despite some conflicting directives from the FDA on CBD-infused products, both national pharmacy/grocery chains are marching ahead with the sales of cannabidiol (CBD) consumer goods.
The non-psychoactive component to the cannabis plant, CBD is known to relieve many ailments including anxiety, inflammation and even more acute conditions such as epilepsy and tumor growth.
Since the December 2018 passage of the 2018 Farm Bill, and the resulting legalization of the production of industrialized hemp and derivative products, including hemp-based CBD, the CBD market has rocketed into the collective conscious of American consumers.
However the FDA still has domain over how CBD can be used, marketed and sold in products outside the spectrum of pharma medicines. Products including soaps, creams, lotions, oils, edible supplements all fall under the FDA’s watchful eye and are subject to its oversight.
In a December 20, 2018 statement after the signing of the Farm Bill, FDA Commissioner Scott Gottlieb stated “It’s unlawful under the [Federal Food, Drug, and Cosmetic Act] to introduce food or food containing added CBD or THC into interstate commerce, or to market CBD or THC products as, or in, dietary supplements, regardless of whether the substances are hemp-derived. This is because both CBD and THC are active ingredients in FDA-approved drugs and were the subject of substantial clinical investigations before they were marketed as foods or dietary supplements.”
That FDA directive has not prevented Walgreens and CVS from entering into the market and placing CBD products on over 2,300 store shelves nationwide.
Given the endorsement of such nationally recognized brands and retail outlets putting their weight behind CBD, it seems we may have reached a tipping point on the national retail front. Time, of course, will tell.